SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,000 | 0.0% | 29 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | -25.0% | 29 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $4,000 | -42.9% | 29 | -46.3% | 0.00% | -33.3% |
| Q2 2018 | $7,000 | +40.0% | 54 | -25.0% | 0.00% | +50.0% |
| Q1 2018 | $5,000 | -54.5% | 72 | -62.7% | 0.00% | -60.0% |
| Q4 2017 | $11,000 | +22.2% | 193 | 0.0% | 0.01% | +25.0% |
| Q3 2017 | $9,000 | +125.0% | 193 | +82.1% | 0.00% | +100.0% |
| Q2 2017 | $4,000 | +33.3% | 106 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $3,000 | -57.1% | 106 | -4.5% | 0.00% | -60.0% |
| Q3 2016 | $7,000 | – | 111 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |